Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Mark Froimson, MD, MBA is the Quality Review Officer for the Orthopaedic and Rheumatologic Institute, charged with initiating and monitoring quality improvement efforts for the entire institute. He joined the Section of Adult Reconstruction Surgery in 1999, after serving as Director of Joint Reconstruction at another Cleveland academic center. He specializes in the surgical care of the hip and knee, with particular emphasis on primary and revision joint replacement and arthroscopy. Dr. Froimson accepts new patients with hip and knee problems. He conducts a clinic at the Main Cleveland Clinic Campus as well as at the Beachwood Family Health Center.
Dr. Froimson's research interests include evaluation of outcomes of joint replacement with particular emphasis on reducing complications. He has studied implant fixation, minimally invasive surgery, hip arthroscopy, partial joint resurfacing, alternative bearing surfaces, mobile bearing knee replacement and avascular necrosis of the hip. He is active in the education of orthopaedic residents, fellows and medical students, and lectures nationally and internationally on advances in hip and knee replacement.
Dr. Froimson was awarded membership into the Alpha Omega Alpha Medical Honor Society, received the Frank E. Stinchfield Award for Excellence in Orthopaedic Research and has been named to the list of Best Doctors numerous times. He was awarded a traveling fellowship from the Mid-America Orthopaedic Society, which he used to study the indications and effectiveness of arthroscopy of the hip.
He currently serves as President of the Cleveland Orthopaedic Society and is Executive Vice Chair of the Board of Trustees for the Northeastern Ohio Chapter of the Arthritis Foundation. He is a member of the American Academy of Orthopaedic Surgery, the American Orthopaedic Association, the Orthopaedic Research Society, the American Association of Hip and Knee Surgeons and numerous other national and international societies.
Hip and knee replacement, hip and knee arthroscopy, partial joint replacement, osteonecrosis, complication prevention, hip and knee total joint replacement revisions and infections
Innovations & Patents
Product and surgical technique development -- Corail Total Hip System
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Froimson's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.